Campbell L, Gumbleton M, Ritchie K
Pharmaceutical Cell Biology, Welsh School of Pharmacy, Cardiff University, Cardiff CF10 3XF, UK.
Adv Drug Deliv Rev. 2001 Jul 28;49(3):325-35. doi: 10.1016/s0169-409x(01)00145-4.
There has been an exponential growth in caveolae research since the early 1990s. The caveolae membrane system comprises unique lipid and protein domains, and fulfills a role in a wide range of processes. At the plasma membrane caveolae serve to compartmentalise and integrate a wide range of signal transduction processes. A key structural and functional protein for caveolae is caveolin. Caveolin proteins possess a 'scaffolding' domain which for caveolins-1 and -3 appear central to many of the reported signal regulation functions for caveolae. Caveolae or caveolin protein are increasingly implicated in the molecular pathology of a number of diseases. Opportunities exist for basic and applied investigators working within the pharmaceutical sciences to exploit the caveolae membrane system to identify novel pharmacological targets and therapeutic strategies, including the delivery of pharmacologically active caveolin based peptides.
自20世纪90年代初以来,小窝研究呈指数级增长。小窝膜系统由独特的脂质和蛋白质结构域组成,并在广泛的过程中发挥作用。在质膜上,小窝有助于分隔和整合多种信号转导过程。小窝的一种关键结构和功能蛋白是小窝蛋白。小窝蛋白具有一个“支架”结构域,对于小窝蛋白-1和-3而言,该结构域似乎是许多报道的小窝信号调节功能的核心。小窝或小窝蛋白越来越多地与多种疾病的分子病理学相关。制药科学领域的基础和应用研究人员有机会利用小窝膜系统来识别新的药理学靶点和治疗策略,包括递送具有药理活性的基于小窝蛋白的肽。